These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 251069

  • 1. Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin-resistant mutants.
    Miller MH, Wexler MA, Steigbigel NH.
    Antimicrob Agents Chemother; 1978 Sep; 14(3):336-43. PubMed ID: 251069
    [Abstract] [Full Text] [Related]

  • 2. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.
    Sande MA, Courtney KB.
    J Lab Clin Med; 1976 Jul; 88(1):118-24. PubMed ID: 1047088
    [Abstract] [Full Text] [Related]

  • 3. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus.
    Fernandez-Guerrero M, Rouse M, Henry N, Wilson W.
    Antimicrob Agents Chemother; 1988 May; 32(5):747-51. PubMed ID: 3164989
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of ampicillin plus a beta-lactamase inhibitor (CP-45,899) in experimental endocarditis due to Staphylococcus aureus.
    Washburn RG, Durack DT.
    J Infect Dis; 1981 Sep; 144(3):237-43. PubMed ID: 6268715
    [Abstract] [Full Text] [Related]

  • 5. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus.
    Chambers HF, Sande MA.
    Antimicrob Agents Chemother; 1984 Jul; 26(1):61-4. PubMed ID: 6236747
    [Abstract] [Full Text] [Related]

  • 6. Penicillinase-resistant penicillin/gentamicin synergism. Effect in patients with Staphylococcus aureus bacteremia.
    Licht JH.
    Arch Intern Med; 1979 Oct; 139(10):1094-8. PubMed ID: 258599
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of nafcillin, methicillin, and cephalothin in experimental Staphylococcus aureus endocarditis.
    Carrizosa J, Kobasa WD, Kaye D.
    Antimicrob Agents Chemother; 1979 May; 15(5):735-7. PubMed ID: 525991
    [Abstract] [Full Text] [Related]

  • 8. Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis.
    Scheld WM, Keeley JM.
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():65-78. PubMed ID: 6421794
    [Abstract] [Full Text] [Related]

  • 9. Comparison of ceforanide, cefazolin, methicillin, and nafcillin in Staphylococcus aureus endocarditis therapy in rabbits.
    Carrizosa J, Kobasa WD, Kaye D.
    Antimicrob Agents Chemother; 1980 Oct; 18(4):562-5. PubMed ID: 7447418
    [Abstract] [Full Text] [Related]

  • 10. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.
    Chambers HF, Hackbarth CJ, Drake TA, Rusnak MG, Sande MA.
    J Infect Dis; 1984 Jun; 149(6):894-903. PubMed ID: 6564133
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus.
    Chambers HF, Xiang Q, Liu, Chow LL, Hackbarth C.
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2742-6. PubMed ID: 10543757
    [Abstract] [Full Text] [Related]

  • 12. Antibiotic prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
    Archer GL, Vazquez GJ, Johnston JL.
    J Infect Dis; 1980 Nov; 142(5):725-31. PubMed ID: 7462687
    [Abstract] [Full Text] [Related]

  • 13. Laboratory tests for defining bactericidal activity as predictors of antibiotic efficacy in the treatment of endocarditis due to Staphylococcus aureus in rabbits.
    Fass RJ.
    J Infect Dis; 1984 Jun; 149(6):904-12. PubMed ID: 6736681
    [Abstract] [Full Text] [Related]

  • 14. Nafcillin therapy for Staphylococcus aureus endocarditis.
    Masur H, Murray HW, Roberts RB.
    Antimicrob Agents Chemother; 1978 Sep; 14(3):457-61. PubMed ID: 708023
    [Abstract] [Full Text] [Related]

  • 15. Antibiotic therapy of experimental Staphylococcus epidermidis endocarditis.
    Vazquez GJ, Archer GL.
    Antimicrob Agents Chemother; 1980 Feb; 17(2):280-5. PubMed ID: 7387148
    [Abstract] [Full Text] [Related]

  • 16. Comparison of methicillin, nafcillin, and oxacillin in therapy of Staphylococcus aureus endocarditis in rabbits.
    Egert J, Carrizosa J, Kaye D, Kobasa WD.
    J Lab Clin Med; 1977 Jun; 89(6):1262-8. PubMed ID: 864305
    [Abstract] [Full Text] [Related]

  • 17. Emergence of resistance to cephalothin and gentamicin during combination therapy for methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
    Chambers HF, Miller MH.
    J Infect Dis; 1987 Mar; 155(3):581-5. PubMed ID: 3643249
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of Staphylococcus aureus endocarditis in rats with coumermycin A1 and ciprofloxacin, alone or in combination.
    Perronne CM, Malinverni R, Glauser MP.
    Antimicrob Agents Chemother; 1987 Apr; 31(4):539-43. PubMed ID: 3606060
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureus.
    Carpenter TC, Hackbarth CJ, Chambers HF, Sande MA.
    Antimicrob Agents Chemother; 1986 Sep; 30(3):382-4. PubMed ID: 3640590
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of ceftriaxone and gentamicin given once a day by using human-like pharmacokinetics in treatment of experimental staphylococcal endocarditis.
    Gavaldà J, López P, Martín T, Gomis X, Ramírez JL, Azuaje C, Almirante B, Pahissa A.
    Antimicrob Agents Chemother; 2002 Feb; 46(2):378-84. PubMed ID: 11796345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.